To tackle the threat of counterfeits to patient health, Pfizer is collaborating with industry stakeholders to ensure patients have the information they need to avoid counterfeit medicines.
Counterfeit medicines often miss key ingredients and dosages or contain added harmful ingredients, a stateme
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Damilola Odifa
Damilola Odifa is a graduate of Mass communication department from the University of Lagos with nearly 2 years experience in content writing.
She currently works as a journalist in BusinessDay Media, West Africa's leading provider of business intelligence and information, where she writes on the business of agriculture, and the environment.
